H. Schwarzenbach, D. Hoon, and K. Pantel, Cell-free nucleic acids as biomarkers in cancer patients, Nat Rev Cancer, vol.11, pp.426-463, 2011.

L. A. Diaz and A. Bardelli, Liquid biopsies: genotyping circulating tumor DNA, J Clin Oncol, vol.32, pp.579-86, 2014.

J. Y. Douillard, G. Ostoros, M. Cobo, T. Ciuleanu, R. Cole et al., Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status, J Thorac Oncol, vol.9, pp.1345-53, 2014.

D. Mattos-arruda, L. Weigelt, B. Cortes, J. Won, H. H. Ng et al., Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle, Ann Oncol, vol.25, pp.1729-1764, 2014.

E. Izumchenko, X. Chang, M. Brait, E. Fertig, L. T. Kagohara et al., Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA, Nat Commun, vol.6, p.8258, 2015.

S. J. Dawson, D. Tsui, M. Murtaza, H. Biggs, O. M. Rueda et al., Analysis of circulating tumor DNA to monitor metastatic breast cancer, N Engl J Med, vol.368, pp.1199-209, 2013.

M. Murtaza, S. J. Dawson, K. Rueda, O. M. Provenzano, E. Grant et al., Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer, Nat Commun, vol.6, pp.1-6, 2015.

F. Diehl, M. Li, D. Dressman, Y. He, D. Shen et al., Detection and quantification of mutations in the plasma of patients with colorectal tumors, Proc Natl Acad Sci U S A, vol.102, pp.16368-73, 2005.

M. Qiu, J. Wang, Y. Xu, X. Ding, M. Li et al., Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysis, Cancer Epidemiol Biomarkers Prev, vol.24, pp.206-218, 2015.

A. R. Thierry, F. Mouliere, E. Messaoudi, S. Mollevi, C. Lopez-crapez et al., Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA, Nat Med, vol.20, pp.430-435, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02168071

K. L. Spindler, N. Pallisgaard, I. Vogelius, and A. Jakobsen, Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan, Clin Cancer Res, vol.18, pp.1177-85, 2012.

V. Taly, D. Pekin, L. Benhaim, S. K. Kotsopoulos, L. Corre et al., Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients, Clin Chem, vol.59, pp.1722-1753, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02299581

T. Forshew, M. Murtaza, C. Parkinson, D. Gale, D. W. Tsui et al., Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA, Sci Transl Med, vol.4, pp.136-68, 2012.

I. Kinde, J. Wu, N. Papadopoulos, K. W. Kinzler, and B. Vogelstein, Detection and quantification of rare mutations with massively parallel sequencing, Proc Natl Acad Sci U S A, vol.108, pp.9530-9535, 2011.

A. Didelot, S. K. Kotsopoulos, A. Lupo, D. Pekin, X. Li et al., Multiplex picoliter-droplet digital PCR for quantitative assessment of DNA integrity in clinical samples, Clin Chem, vol.59, pp.815-838, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02299583

V. Taly, D. Pekin, A. El-abed, and P. Laurent-puig, Detecting biomarkers with microdroplet technology, Trends Mol Med, vol.18, pp.405-421, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02299585

M. Ong, S. Carreira, J. Goodall, J. Mateo, I. Figueiredo et al., Validation and utilisation of highcoverage next-generation sequencing to deliver the pharmacological audit trail, Br J Cancer, vol.111, pp.828-864, 2014.

J. S. Frenel, S. Carreira, J. Goodall, D. Roda, R. Perez-lopez et al., Serial next-generation sequencing of circulating cell-free DNA evaluating tumor clone response to molecularly targeted drug administration, Clin Cancer Res, vol.21, pp.4586-96, 2015.

D. Pekin, Y. Skhiri, J. Baret, L. Corre, D. Mazutis et al., Quantitative and sensitive detection of rare mutations using droplet-based microfluidics, Lab Chip, vol.11, pp.2156-66, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02148770

D. Sims, I. Sudbery, N. E. Ilott, A. Heger, and C. P. Ponting, Sequencing depth and coverage: key considerations in genomic analyses, Nat Rev Genet, vol.15, pp.121-153, 2014.

N. J. Loman, R. V. Misra, T. J. Dallman, C. Constantinidou, S. E. Gharbia et al., Performance comparison of benchtop high-throughput sequencing platforms, Nat Biotechnol, vol.30, pp.434-443, 2012.

M. G. Ross, C. Russ, M. Costello, A. Hollinger, N. J. Lennon et al., Characterizing and measuring bias in sequence data, Genome Biol, vol.14, p.51, 2013.

H. Xu, J. Dicarlo, R. V. Satya, Q. Peng, and Y. Wang, Comparison of somatic mutation calling methods in amplicon and whole exome sequence data, BMC Genomics, vol.15, p.244, 2014.

A. M. Newman, S. V. Bratman, J. To, J. F. Wynne, and N. Eclov,

L. A. Modlin, An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage, Nat Med, vol.20, pp.548-54, 2014.

C. P. Paweletz, A. G. Sacher, C. K. Raymond, R. S. Alden, A. O'connell et al., Bias-corrected targeted next-generation sequencing for rapid, multiplexed detection of actionable alterations in cell-free DNA from advanced lung cancer patients, Clin Cancer Res, vol.22, pp.915-937, 2016.

D. I. Lou, J. A. Hussmann, R. M. Mcbee, A. Acevedo, R. Andino et al., High-throughput DNA sequencing errors are reduced by orders of magnitude using circle sequencing, Proc Natl Acad Sci U S A, vol.110, pp.19872-19879, 2013.

M. W. Schmitt, S. R. Kennedy, J. J. Salk, E. J. Fox, J. B. Hiatt et al., Detection of ultra-rare mutations by nextgeneration sequencing, Proc Natl Acad Sci U S A, vol.109, pp.14508-14521, 2012.

S. R. Kennedy, M. W. Schmitt, E. J. Fox, B. F. Kohrn, J. J. Salk et al., Detecting ultralow-frequency mutations by Duplex Sequencing, Nat Protoc, vol.9, pp.2586-606, 2014.

A. M. Newman, A. F. Lovejoy, D. M. Klass, D. M. Kurtz, J. J. Chabon et al., Integrated digital error suppression for improved detection of circulating tumor DNA, Nat Biotechnol, vol.34, pp.547-55, 2016.

X. Cai, F. Janku, Q. Zhan, and J. B. Fan, Accessing genetic information with liquid biopsies, Trends Genet, vol.31, pp.564-75, 2015.

, Comprehensive R Archive Network (CRAN). Plasma Mutation Detector Package, 2016.

A. Mckenna, M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis et al., The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data, Genome Res, vol.20, pp.1297-303, 2010.

M. Morgan, H. Pagès, V. Obenchain, and H. N. Rsamtools, Binary alignment (BAM), FASTA, variant call (BCF), and tabix file import, 2016.

M. Hubert and E. Vandervieren, An adjusted boxplot for skewed distributions, Comput Stat Data Analy, vol.52, pp.5186-201, 2008.

B. B. Tops, N. Normanno, H. Kurth, E. Amato, A. Mafficini et al., Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium, BMC Cancer, vol.15, p.26, 2015.

J. M. Rothberg, W. Hinz, T. M. Rearick, J. Schultz, W. Mileski et al., An integrated semiconductor device enabling non-optical genome sequencing, Nature, vol.475, pp.348-52, 2012.

J. Li, L. Wang, H. Mamon, M. H. Kulke, R. Berbeco et al., Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing, Nat Med, vol.14, pp.579-84, 2008.

C. A. Milbury, M. Correll, J. Quackenbush, R. Rubio, and G. M. Makrigiorgos, COLD-PCR enrichment of rare cancer mutations prior to targeted amplicon resequencing, Clin Chem, vol.58, pp.580-589, 2012.

M. Gerstung, C. Beisel, M. Rechsteiner, P. Wild, P. Schraml et al., Reliable detection of subclonal singlenucleotide variants in tumour cell populations, Nat Commun, vol.3, p.811, 2012.

M. T. Chang, S. Asthana, S. P. Gao, B. H. Lee, J. S. Chapman et al., Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity, Nat Biotechnol, vol.34, pp.155-63, 2016.

M. Gerstung, E. Papaemmanuil, and P. J. Campbell, Subclonal variant calling with multiple samples and prior knowledge, Bioinformatics, vol.30, pp.1198-204, 2014.

H. A. Yu, M. E. Arcila, N. Rekhtman, C. S. Sima, M. F. Zakowski et al., Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers, Clin Cancer Res, vol.19, pp.2240-2247, 2013.

J. Y. Lee, X. Qing, W. Xiumin, B. Yali, C. S. Bak et al., Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02), Oncotarget, vol.7, pp.6984-93, 2016.